Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00954096 · ClinicalTrials.gov registry record · NA

Nicotine Patch, Blood Flow and Oxidative Stress Study

A NA study of Healthy, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT00954096: Completed NA study of Healthy, sponsored by University of Pennsylvania.

NCT00954096 is a NA study of Healthy that has completed, run by University of Pennsylvania. The registered enrollment target is 55 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00954096, a NA study of Healthy, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study will address the hypothesis that nicotine, like cigarette smoking acting as a pro-oxidant may have adverse effects on arterial function.

Conditions Studied

Interventions

  • DRUG transdermal nicotine patch (7mg)

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2002-10
Est. Completion 2006-12
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT00954096

The ClinicalTrials.gov registry entry for NCT00954096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which transdermal nicotine patch (7mg) is the first listed.

NCT00954096 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00954096 about?

NCT00954096 is a clinical study titled "Nicotine Patch, Blood Flow and Oxidative Stress Study". This study will address the hypothesis that nicotine, like cigarette smoking acting as a pro-oxidant may have adverse effects on arterial function.

What is the current status of trial NCT00954096?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2002-10. Estimated completion is 2006-12.

What conditions does trial NCT00954096 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00954096?

The interventions under investigation include: transdermal nicotine patch (7mg) (DRUG).

Who is sponsoring clinical trial NCT00954096?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00954096 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.